- Home
- TH vs TNGX Comparison
TH vs TNGX Comparison
Compare TH & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TH
- TNGX
- Stock Information
- Founded
- TH 1978
- TNGX 2014
- Country
- TH United States
- TNGX United States
- Employees
- TH N/A
- TNGX N/A
- Industry
- TH Hotels/Resorts
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- TH Consumer Discretionary
- TNGX Health Care
- Exchange
- TH Nasdaq
- TNGX Nasdaq
- Market Cap
- TH 692.6M
- TNGX 723.2M
- IPO Year
- TH N/A
- TNGX N/A
- Fundamental
- Price
- TH $8.72
- TNGX $6.82
- Analyst Decision
- TH Buy
- TNGX Strong Buy
- Analyst Count
- TH 3
- TNGX 6
- Target Price
- TH $13.00
- TNGX $10.00
- AVG Volume (30 Days)
- TH 430.5K
- TNGX 1.5M
- Earning Date
- TH 11-11-2025
- TNGX 11-05-2025
- Dividend Yield
- TH N/A
- TNGX N/A
- EPS Growth
- TH N/A
- TNGX N/A
- EPS
- TH 0.10
- TNGX N/A
- Revenue
- TH $310,382,000.00
- TNGX $24,296,000.00
- Revenue This Year
- TH N/A
- TNGX $6.56
- Revenue Next Year
- TH N/A
- TNGX N/A
- P/E Ratio
- TH $84.66
- TNGX N/A
- Revenue Growth
- TH N/A
- TNGX N/A
- 52 Week Low
- TH $4.00
- TNGX $1.03
- 52 Week High
- TH $11.10
- TNGX $10.81
- Technical
- Relative Strength Index (RSI)
- TH 54.80
- TNGX 52.79
- Support Level
- TH $8.67
- TNGX $6.25
- Resistance Level
- TH $9.16
- TNGX $6.90
- Average True Range (ATR)
- TH 0.23
- TNGX 0.41
- MACD
- TH -0.05
- TNGX -0.04
- Stochastic Oscillator
- TH 29.03
- TNGX 49.57
About TH Target Hospitality Corp.
Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.